DrugPatentWatch Database Preview

Details for Patent: 7,064,148

« Back to Dashboard

Which drugs does patent 7,064,148 protect, and when does it expire?

Patent 7,064,148 protects AMITIZA and is included in one NDA.

This patent has fourteen patent family members in ten countries.

Summary for Patent: 7,064,148

Title:	Chloride channel opener
Abstract:	Disclosed is a novel use of a prostaglandin compound as a chloride channel opener. According to the instant invention, chloride channels in a mammalian subject can be opened by a prostaglandin compound to facilitate chloride ion transportation.
Inventor(s):	Ueno; Ryuji (Montgomery, MD), Cuppoletti; John (Cincinnati, OH)
Assignee:	Sucampo AG (Zug, CH)
Application Number:	10/231,341
Patent Litigation and PTAB cases:	See patent lawsuits and PTAB cases for patent 7,064,148
Patent Claim Types: see list of patent claims	Use;

Drugs Protected by US Patent 7,064,148

Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Patented / Exclusive Use	Submissiondate
Sucampo Pharma Llc	AMITIZA	lubiprostone	CAPSULE;ORAL	021908-002	Apr 29, 2008		RX	Yes	No						METHOD OF TREATING CONSTIPATION IN A PATIENT WITH IRRITABLE BOWEL SYNDROME BY OPENING CHLORIDE CHANNELS (CIC)
Sucampo Pharma Llc	AMITIZA	lubiprostone	CAPSULE;ORAL	021908-002	Apr 29, 2008		RX	Yes	No						METHOD FOR TREATING CONSTIPATION BY OPENING CIC CHANNELS IN A MAMMALIAN SUBJECT
Sucampo Pharma Llc	AMITIZA	lubiprostone	CAPSULE;ORAL	021908-001	Jan 31, 2006		RX	Yes	Yes						METHOD FOR TREATING CONSTIPATION IN A PATIENT WITH OPIOID-INDUCED CONSTIPATION BY OPENING CIC CHANNELS

International Family Members for US Patent 7,064,148

Country	Patent Number	Estimated Expiration	Supplementary Protection Certificate	SPC Country	SPC Expiration
Argentina	036391
Argentina	104392
Australia	2002330747